Translational Autoimmunity, Volume 6

Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the founding President of the Universal Scientific Education and Research Network (USERN). Professor Rezaei has already been the Director of more than 55 research projects and has designed and participated in several international collaborative projects. Professor Rezaei is an editorial assistant or board member for more than 30 international journals. He has edited more than 35 international books, has presented more than 500 lectures/posters in congresses/meetings, and has published more than 1,000 scientific papers in the international journals.

• 1. Introduction on Autoimmune Rheumatic Diseases2. Bone health in autoimmune inflammatory rheumatic diseases3. Rheumatic diseases: from bench to bedside4. Rheumatic fever: from pathogenesis to vaccine perspectives5. Changes in future rheumatoid arthritis treatment in the light of Epstein-Barr virus infection6. Rheumatologic diseases: the microbiota-immunity axis in development and treatment7. The diagnostic laboratory tests in rheumatic diseases8. Autoantibody profiling in autoimmune rheumatic diseases: from basic research to clinical use9. Air pollution and rheumatoid arthritis: current knowledge and state-of-the-art10. Advanced therapies for rheumatoid arthritis11. A tolerogenic dendritic cell-based therapy targeting heat shock protein specific regulatory T cells in rheumatoid arthritis12. T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis13. Biomaterials as tools for re-balancing the skewed immunity in rheumatoid arthritis14. Immunopathogenesis of systemic lupus erythematosus15. Challenges in systemic lupus erythematosus: from bench to bedside16. Therapeutic potential in systemic lupus erythematosus17. The pathology and potential clinical applicability of interfering T cells in systemic lupus erythematosus18. Rheumatic chorea19. Management of the rheumatoid hind foot and ankle20. Immunopathogenesis of scleroderma21. Skin manifestations and autoimmune disturbances in dermatomyositis22. T cells in systemic sclerosis23. Etiopathogenesis of Behçet's disease: the role of genetic, immunological and environmental factors24. Interleukin-1 family in Behçet's disease: inflammatory and anti-inflammatory mediators25. Salivary gland regeneration and repair in Sjogren’s syndrome26. Translational regulation of bone and joint inflammation by type 2 innate lymphoid cells27. Arboviruses (Alphavirus) related to autoimmune rheumatic diseases: Triggers and possible therapeutic interventions28. Rheumatologic manifestations of autoinflammatory disorders